— Know what they know.
Not Investment Advice

LDXHF OTC

Lumos Diagnostics Holdings Ltd.
1W: -11.9% 1M: -15.5% 3M: -12.5% YTD: -65.7% 1Y: -39.1% 3Y: -5.4% 5Y: -90.3%
$0.07
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Sell · Power 40 · $66.1M mcap · 573M float · 0.0049% daily turnover · Short 39% of daily vol

Income Trends

Revenue
$13M +7.7% ▲
5Y CAGR: -6.6%
Gross Profit
-$8M -200.0% ▼
Operating Income
-$14M -84.0% ▼
Net Income
-$5M +29.6% ▲
EPS (Diluted)
$-0.01 +41.5% ▲
EBITDA
-$12M -155.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$12M$11M$11M$12M$13M
YoY Growth-38.7%-9.4%+5.7%+12.3%+7.7%
Cost of Revenue$7M$15M$4M$5M$21M
Gross Profit$4M-$4M$7M$8M-$8M
Gross Margin38.3%-40.6%63.8%63.2%-58.7%
R&D Expenses$1M$246K$69K$106K$424K
SG&A Expenses$19M$10M$11M$12M$6M
Operating Expenses$15M$6M$14M$16M$7M
Operating Income-$24M-$7M-$7M-$8M-$14M
Operating Margin-205.4%-62.3%-64.0%-62.7%-107.1%
Interest Expense$572K$2M$1M$591K$2M
Income Before Tax-$46M-$9M-$9M-$7M-$6M
Tax Expense$0$0$0$0-$510K
Net Income-$46M-$9M-$9M-$7M-$5M
Net Margin-393.2%-84.3%-77.2%-57.5%-37.5%
EPS (Diluted)$-0.30$-0.04$-0.02$-0.01$-0.01
EBITDA-$40M-$3M-$5M-$5M-$12M
Shares Outstanding152M235M494M680M813M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms